Lexeo Therapeutics Common Stock Price Patterns
| LXEO Stock | 7.24 0.17 2.40% |
Momentum 30
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.42) | EPS Estimate Current Year (1.92) | EPS Estimate Next Year (1.47) | Wall Street Target Price 19.6364 | EPS Estimate Current Quarter (0.44) |
Using Lexeo Therapeutics hype-based prediction, you can estimate the value of Lexeo Therapeutics Common from the perspective of Lexeo Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Lexeo Therapeutics using Lexeo Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Lexeo using crowd psychology based on the activity and movement of Lexeo Therapeutics' stock price.
Lexeo Therapeutics Implied Volatility | 2.64 |
Lexeo Therapeutics' implied volatility exposes the market's sentiment of Lexeo Therapeutics Common stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Lexeo Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Lexeo Therapeutics stock will not fluctuate a lot when Lexeo Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Lexeo Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Lexeo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Lexeo Therapeutics after-hype prediction price | USD 6.99 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Lexeo contract
Based on the Rule 16, the options market is currently suggesting that Lexeo Therapeutics Common will have an average daily up or down price movement of about 0.17% per day over the life of the 2026-05-15 option contract. With Lexeo Therapeutics trading at USD 7.24, that is roughly USD 0.0119 . If you think that the market is fully incorporating Lexeo Therapeutics' daily price movement you should consider acquiring Lexeo Therapeutics Common options at the current volatility level of 2.64%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Lexeo Therapeutics Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lexeo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lexeo Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Lexeo Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lexeo Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Lexeo Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Lexeo Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Lexeo Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lexeo Therapeutics' historical news coverage. Lexeo Therapeutics' after-hype downside and upside margins for the prediction period are 2.39 and 11.59, respectively. We have considered Lexeo Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Lexeo Therapeutics is slightly risky at this time. Analysis and calculation of next after-hype price of Lexeo Therapeutics Common is based on 3 months time horizon.
Lexeo Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Lexeo Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lexeo Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lexeo Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.31 | 4.60 | 0.25 | 0.08 | 28 Events / Month | 7 Events / Month | In about 28 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
7.24 | 6.99 | 3.45 |
|
Lexeo Therapeutics Hype Timeline
Lexeo Therapeutics Common is now traded for 7.24. The entity has historical hype elasticity of -0.25, and average elasticity to hype of competition of -0.08. Lexeo is forecasted to decline in value after the next headline, with the price expected to drop to 6.99. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -3.45%, whereas the daily expected return is now at -0.31%. The volatility of related hype on Lexeo Therapeutics is about 1684.98%, with the expected price after the next announcement by competition of 7.16. About 99.0% of the company shares are owned by institutional investors. The book value of Lexeo Therapeutics was now reported as 2.2. The company recorded a loss per share of 2.5. Lexeo Therapeutics Common had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 28 days. Check out Lexeo Therapeutics Basic Forecasting Models to cross-verify your projections.Lexeo Therapeutics Related Hype Analysis
Having access to credible news sources related to Lexeo Therapeutics' direct competition is more important than ever and may enhance your ability to predict Lexeo Therapeutics' future price movements. Getting to know how Lexeo Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lexeo Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KYTX | Kyverna Therapeutics Common | (0.31) | 21 per month | 7.55 | 0.06 | 10.60 | (9.02) | 55.75 | |
| CTNM | Contineum Therapeutics Class | (0.81) | 15 per month | 3.72 | 0.12 | 7.89 | (5.55) | 26.95 | |
| SLN | Silence Therapeutics PLC | (0.04) | 7 per month | 0.00 | (0.04) | 9.23 | (5.89) | 23.80 | |
| LRMR | Larimar Therapeutics | (0.03) | 7 per month | 3.67 | 0.10 | 9.77 | (7.23) | 68.47 | |
| CAPR | Capricor Therapeutics | (1.18) | 9 per month | 3.29 | 0.13 | 10.86 | (6.69) | 386.29 | |
| MREO | Mereo BioPharma Group | 0.52 | 19 per month | 0.00 | (0.01) | 16.33 | (9.52) | 101.95 | |
| VYGR | Voyager Therapeutics | 0.03 | 6 per month | 2.93 | 0.01 | 5.59 | (5.23) | 19.71 | |
| DBVT | DBV Technologies | (0.47) | 9 per month | 4.02 | 0.16 | 10.77 | (6.81) | 36.36 | |
| AMRN | Amarin PLC | 0.59 | 17 per month | 0.00 | (0.04) | 4.94 | (4.37) | 26.36 | |
| VNDA | Vanda Pharmaceuticals | (1.03) | 9 per month | 5.13 | 0.11 | 11.39 | (6.46) | 49.80 |
Lexeo Therapeutics Additional Predictive Modules
Most predictive techniques to examine Lexeo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lexeo using various technical indicators. When you analyze Lexeo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Lexeo Therapeutics Predictive Indicators
The successful prediction of Lexeo Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lexeo Therapeutics Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lexeo Therapeutics based on analysis of Lexeo Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lexeo Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lexeo Therapeutics's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Current Ratio | 7.21 | 5.52 | 6.35 | 6.03 | Net Debt To EBITDA | 1.71 | 0.26 | 0.3 | 0.28 |
Pair Trading with Lexeo Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lexeo Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexeo Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Lexeo Stock
Moving against Lexeo Stock
| 0.8 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.75 | VALN | Valneva SE ADR | PairCorr |
| 0.75 | DNTH | Dianthus Therapeutics Buyout Trend | PairCorr |
| 0.71 | DNLI | Denali Therapeutics | PairCorr |
| 0.65 | GXEA | Galapagos NV | PairCorr |
| 0.62 | CMB | Cambium Bio | PairCorr |
The ability to find closely correlated positions to Lexeo Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lexeo Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lexeo Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lexeo Therapeutics Common to buy it.
The correlation of Lexeo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lexeo Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lexeo Therapeutics Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lexeo Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Lexeo Therapeutics Basic Forecasting Models to cross-verify your projections. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Will Biotechnology sector continue expanding? Could Lexeo diversify its offerings? Factors like these will boost the valuation of Lexeo Therapeutics. Expected growth trajectory for Lexeo significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Lexeo Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Lexeo Therapeutics Common using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Lexeo Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Lexeo Therapeutics' market price to deviate significantly from intrinsic value.
Understanding that Lexeo Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Lexeo Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Lexeo Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.